New-generation anti-obesity drug Wegovy, made by the same company ... with their GP’s approval. The ANSM said in a press release that the use of this type of drug as a treatment for obesity ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
The chances of your employer covering an anti-obesity drug depends on its size — bigger organizations are much more likely to offer the benefit than smaller ones. Workers are eligible for the ...
An industry group representing companies that manufactured the copycat versions of Eli Lilly's (NYSE:LLY) highly popular ...
Medicare coverage of weight loss drugs, if authorized, would increase federal spending by about $35B from 2026 to 2034, ...
An anti-obesity drug, the first such medicine to become available in Japan, has been approved for manufacturing and sales by an expert panel of the health ministry. The decision, made Nov. 28 ...